Benchmarks ended the last trading session of the week on a positive note after Fed Chair Janet Yellen said there was a possibility of a gradual hike in interest rates sometime this year. The Nasdaq was boosted by a possible deal between Intel and Altera. Gains in bio-tech stocks also helped the Nasdaq end in positive territory. However, benchmarks reported […]
Benchmarks ended in the red for the fourth-straight session after escalating tensions in the Middle-East following an air strike in Yemen dampened investor sentiment. Additionally, the crisis in Yemen drove oil prices higher on Thursday on concerns that it may lead to reduction in oil supply. However, upbeat initial claims data limited some of the day’s losses. The S&P 500 […]
Slump in biotech and technology stocks sent benchmarks to negative territory for third straight sessions on Wednesday. These sectors witnessed intense selling pressure as investors remained concerned that strength in the U.S. dollar will negatively impact earnings growth in upcoming quarters. However, the dollar weakened yesterday against major currencies following release of dismal durable orders data. The Nasdaq witnessed its […]
Related NICEImperial Capital Rates Raft Of Security Companies At Mostly OutperformWedbush Remains Positive On NICE Systems After Management MeetingsIn a report published Tuesday, JMP Securities analyst Greg McDowell downgraded the rating on Nice-Systems Ltd. (ADR) (NASDAQ: NICE) from Market Outperform to Market Perform, and removed the $58.00 price target.In the report, JMP Securities noted, “We are downgrading NICE Systems to […]
Related 13 Management Changes That Happened This Week8-K Filing Shows Bind Therapeutics Closes Offering Of StockRelated Morning Market LosersCerulean Announces Completion of Enrollment of a Phase 1b/2 Study of CRLX101 in Combination with Avastin® in Relapsed Renal Cell CarcinomaCerulean Pharma (CERU) Shares March Higher, Can It Continue? – Tale of the Tape(Zacks)In a recent report, analysts at JMP Securities discussed […]
Strengthening U.S. dollar and a slump in oil prices dragged benchmarks lower on Friday. US crude prices dropped to their lowest levels since Jan 28. Meanwhile, declines in producer prices and consumer confidence added to the bearish sentiment. Benchmarks also posted losses for the third straight week, mostly spooked by sooner-than-expected rate hike fears.For a look at the issues currently […]
Related ATHXMorning Market GainersWhy Investors Are Watching Athersys Ahead Of Stem Cell DataIn a recent report, analysts at Maxim Group discussed the biotechnology sector and gave their outlook for five names in the space. Here’s a rundown of what they had to say.Athersys, Inc. (NASDAQ: ATHX)Analysts believe that Athersys may have found a “sweet spot” for stroke treatment timing, as […]
Benchmarks snapped two-day losses to end in the green on Thursday as mixed economic data reduced fears about sooner-than-expected rate hike. Moreover, mixed economic data put the brakes on dollar rally yesterday. Meanwhile, financial stocks posted solid gains after Fed’s stress tests. However, decline in energy shares following oil price slump limited some of yesterday’s gains. The Dow and S&P […]
Markets extended Tuesday’s losses to end in negative territory yesterday as investors remained concerned about the possibility of a mid-year interest rate hike. Moreover, U.S. dollar continued to gain strength against euro and its other rivals. While, the S&P 500 and Dow finished at their lowest level since Feb 2, the Nasdaq declined to its lowest level since Feb 11.For […]
Gilead, without a doubt, has proven itself to be a leader in the biotechnology industry. The stock has had an extremely bullish pattern over the last four years, growing over 400% in stock price since March 2011. However, over the last 6 months, the stock has seen a loss of about 5%.In fact, there has been a considerable amount of […]
